Vanguard Group
BNR

Vanguard Group’s Burning Rock Biotech BNR Stock Holding History

Vanguard Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,622
Closed -$396K – 4530
2022
Q3 		$396K Sell
16,622
-148,877
-90% -$4.8M ﹤0.01% 4276
2022
Q2 		$4.82M Buy
165,499
+60,162
+57% +$2.69M ﹤0.01% 3395
2022
Q1 		$9.79M Buy
105,337
+2,629
+3% +$228K ﹤0.01% 3169
2021
Q4 		$9.79M Sell
102,708
-4,462
-4% -$611K ﹤0.01% 3217
2021
Q3 		$19.2M Buy
107,170
+99,198
+1,244% +$22M ﹤0.01% 2889
2021
Q2 		$2.35M Buy
+7,972
New +$2.36M ﹤0.01% 3926

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Vanguard Group's BNR Position: Q4 2022 in Review

Vanguard Group sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 16,622 shares — an estimated $396K sold.

Vanguard Group first reported a position in BNR in Q2 2021 and held it in 6 quarters. The position peaked at $19.2M in Q3 2021. 41 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

  • Vanguard Group reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 16,622 Burning Rock Biotech shares in Q4 2022, an estimated $396K.
  • Vanguard Group first reported a position in Burning Rock Biotech in Q2 2021 and held it in 6 quarters.
  • Vanguard Group's Burning Rock Biotech position peaked at $19.2M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.